{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:24:28Z","timestamp":1787793868361,"version":"build-2784847793"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,17]]},"DOI":"10.1093\/ibd\/izaa120","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T05:43:27Z","timestamp":1591940607000},"page":"e77-e78","source":"Crossref","is-referenced-by-count":3,"title":["Eosinophilic Fasciitis in a Patient With Crohn\u2019s Disease Treated With Infliximab. A Rare Coexistence or a Drug-related Manifestation?"],"prefix":"10.1093","volume":"26","author":[{"given":"Afroditi","family":"Mpitouli","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Venizeleio General Hospital , Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kougkas","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion , Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Avgoustidis","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion , Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Ergazakis","sequence":"additional","affiliation":[{"name":"Department of Magnetic Resonance Imaging, \u201cPrognosis\u201d Diagnostic Center , Larnaca, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Karmiris","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Venizeleio General Hospital , Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"2022092616074634600_CIT0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11926-017-0700-6","article-title":"Eosinophilic fasciitis: an updated review on diagnosis and treatment","volume":"19","author":"Mazori","year":"2017","journal-title":"Curr Rheumatol Rep."},{"key":"2022092616074634600_CIT0002","first-page":"7906013","article-title":"Development of eosinophilic fasciitis during infliximab therapy for psoriatic arthritis","volume":"2016","author":"Hariman","year":"2016","journal-title":"Case Rep Rheumatol."},{"key":"2022092616074634600_CIT0003","article-title":"Development of eosinophilic fasciitis during treatment with certolizumab pegol for ankylosing spondylitis","author":"Debusschere","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2022092616074634600_CIT0004","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/rheumatology\/keq062","article-title":"Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases","volume":"49","author":"Khanna","year":"2010","journal-title":"Rheumatology (Oxford)."},{"key":"2022092616074634600_CIT0005","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.intimp.2011.07.017","article-title":"IFN-\u03b3 and TNF-\u03b1 potentiate prostaglandin D2-induced human eosinophil chemotaxis through up-regulation of CRTH2 surface receptor","volume":"11","author":"El-Shazly","year":"2011","journal-title":"Int Immunopharmacol."},{"key":"2022092616074634600_CIT0006","doi-asserted-by":"crossref","first-page":"e90298","DOI":"10.1371\/journal.pone.0090298","article-title":"Tumour necrosis factor-\u03b1 regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-\u03baB and AP-1","volume":"9","author":"Kankaanranta","year":"2014","journal-title":"Plos One."},{"key":"2022092616074634600_CIT0007","first-page":"1","article-title":"Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study","author":"Akdogan","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"2022092616074634600_CIT0008","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jsps.2018.05.001","article-title":"The relationship between blood eosinophil count and disease activity in ankylosing spondylitis patients treated with TNF-\u03b1 inhibitors","volume":"26","author":"Sargin","year":"2018","journal-title":"Saudi Pharm J."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/26\/8\/e77\/46050374\/ibd_26_8_e77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/26\/8\/e77\/46050374\/ibd_26_8_e77.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T16:25:40Z","timestamp":1664209540000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/26\/8\/e77\/5856325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":8,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,6,12]]},"published-print":{"date-parts":[[2020,7,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaa120","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,6,12]]}}}